Deep Track Capital, LP 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 08:42 am Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Deep Track Capital, LP | 0 0.000% |
-6,345,790 (Position Closed) |
Filing |
| 2021-12-09 4:54 pm Purchase |
2021-12-03 | 13G | Esperion Therapeutics, Inc. ESPR |
Deep Track Capital, LP | 6,345,790 9.990% |
6,345,790 (New Position) |
Filing |